Non-Growth-Promoting Fragment: Unlike full-length hGH, AOD 9604 does not stimulate IGF-1 production, making it a clean model for isolated metabolic research
The research supports each one for different aspects of that repair process
Evidence in humans is early, so peptide therapy should complement, not replace, established rheumatology care
GHK-Cu changes the repair instructions, BPC-157 supports the capillary supply, and TB-4 gives repair cells the internal structure they need to move through tissue
GH/IGF-1 axis modulation Several Sikiric studies (2010-2020) reported indirect modulation of the GH-IGF-1 axis by BPC-157, with moderate induction of GH receptor expression in scar tissue
So why is it that up to 40% of patients can have a subclinical vitamin B12 deficiency